AQR Capital Management - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$50,547
-59.2%
11,755
-65.8%
0.00%
Q2 2022$124,000
-91.1%
34,363
-84.7%
0.00%
-100.0%
Q1 2022$1,395,000
-44.6%
224,606
-37.1%
0.00%
-40.0%
Q4 2021$2,519,000
+15.2%
357,242
+14.0%
0.01%
+25.0%
Q3 2021$2,187,000
+966.8%
313,347
+1174.4%
0.00%
Q2 2021$205,00024,5880.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Harvey Partners, LLC 1,020,036$7,120,0005.32%
Portolan Capital Management 2,358,010$16,459,0001.20%
Acuitas Investments, LLC 375,836$2,623,0001.14%
Parkman Healthcare Partners LLC 475,367$3,318,0000.84%
Adirondack Research & Management Inc. 90,020$628,0000.76%
Archon Capital Management LLC 736,236$5,139,0000.73%
BARD ASSOCIATES INC 294,697$2,057,0000.70%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,621,775$11,320,0000.65%
GLOBEFLEX CAPITAL L P 268,466$1,874,0000.41%
Monarch Partners Asset Management LLC 330,083$2,304,0000.34%
View complete list of HARVARD BIOSCIENCE INC shareholders